Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin
- PMID: 23901101
- PMCID: PMC3746899
- DOI: 10.1073/pnas.1309618110
Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin
Abstract
Complement is an essential component of innate immunity. Its activation results in the assembly of unstable protease complexes, denominated C3/C5 convertases, leading to inflammation and lysis. Regulatory proteins inactivate C3/C5 convertases on host surfaces to avoid collateral tissue damage. On pathogen surfaces, properdin stabilizes C3/C5 convertases to efficiently fight infection. How properdin performs this function is, however, unclear. Using electron microscopy we show that the N- and C-terminal ends of adjacent monomers in properdin oligomers conform a curly vertex that holds together the AP convertase, interacting with both the C345C and vWA domains of C3b and Bb, respectively. Properdin also promotes a large displacement of the TED (thioester-containing domain) and CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor and bone morphogenetic protein 1) domains of C3b, which likely impairs C3-convertase inactivation by regulatory proteins. The combined effect of molecular cross-linking and structural reorganization increases stability of the C3 convertase and facilitates recruitment of fluid-phase C3 convertase to the cell surfaces. Our model explains how properdin mediates the assembly of stabilized C3/C5-convertase clusters, which helps to localize complement amplification to pathogen surfaces.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.Clin Exp Immunol. 2016 Apr;184(1):118-25. doi: 10.1111/cei.12754. Epub 2016 Jan 22. Clin Exp Immunol. 2016. PMID: 26660535 Free PMC article.
-
Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.J Biol Chem. 2016 Apr 8;291(15):8214-30. doi: 10.1074/jbc.M115.693119. Epub 2016 Feb 22. J Biol Chem. 2016. Retraction in: J Biol Chem. 2017 Apr 14;292(15):6094. doi: 10.1074/jbc.A115.693119. PMID: 26903516 Free PMC article. Retracted.
-
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).Mol Immunol. 2008 Apr;45(8):2370-9. doi: 10.1016/j.molimm.2007.11.003. Epub 2007 Dec 21. Mol Immunol. 2008. PMID: 18096230 Free PMC article.
-
[The alternative complement pathway].Pathol Biol (Paris). 1983 Dec;31(10):839-46. Pathol Biol (Paris). 1983. PMID: 6230588 Review. French.
-
Properdin and complement activation: a fresh perspective.Curr Drug Targets. 2008 Feb;9(2):158-64. doi: 10.2174/138945008783502458. Curr Drug Targets. 2008. PMID: 18288967 Review.
Cited by
-
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.Mol Immunol. 2015 Aug;66(2):263-73. doi: 10.1016/j.molimm.2015.03.248. Epub 2015 Apr 11. Mol Immunol. 2015. PMID: 25879158 Free PMC article.
-
Human Properdin Opsonizes Nanoparticles and Triggers a Potent Pro-inflammatory Response by Macrophages without Involving Complement Activation.Front Immunol. 2018 Feb 12;9:131. doi: 10.3389/fimmu.2018.00131. eCollection 2018. Front Immunol. 2018. PMID: 29483907 Free PMC article.
-
Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.Front Pharmacol. 2022 Apr 19;13:855743. doi: 10.3389/fphar.2022.855743. eCollection 2022. Front Pharmacol. 2022. PMID: 35517827 Free PMC article.
-
Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.Front Immunol. 2020 Aug 7;11:1643. doi: 10.3389/fimmu.2020.01643. eCollection 2020. Front Immunol. 2020. PMID: 32849563 Free PMC article.
-
Cryo-EM and the elucidation of new macromolecular structures: Random Conical Tilt revisited.Sci Rep. 2015 Sep 22;5:14290. doi: 10.1038/srep14290. Sci Rep. 2015. PMID: 26390853 Free PMC article.
References
-
- Rodríguez de Córdoba S, Harris CL, Morgan BP, Llorca O. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway. Biochim Biophys Acta. 2011;1812(1):12–22. - PubMed
-
- Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nat Rev Immunol. 2008;8(1):48–58. - PubMed
-
- Hourcade DE. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem. 2006;281(4):2128–2132. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous